The Human Upgrade: Biohacking for Longevity & Performance

Biotech Ninja Moves Are Disrupting How We Age & What We Eat – Jim Mellon with Dave Asprey : 736

Sep 1, 2020
Jim Mellon, a British entrepreneur and prominent investor in longevity and biotech, discusses groundbreaking advancements in combating aging. He shares insights on the financial trends shaping the future of healthcare, emphasizing the importance of curiosity and innovation. The conversation dives into cellular agriculture as a sustainable food source, the science behind supplements like NAD, and the societal implications of longer lifespans. Mellon's visionary ideas present a future where healthier, more energized individuals can contribute to society in meaningful ways.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Multi-Pathway Aging

  • Aging is a complex process influenced by multiple pathways, not a single cause.
  • Juvenescence targets multiple aging pathways with various projects for a comprehensive approach.
INSIGHT

Big Pharma as Marketing Machines

  • Big Pharma primarily markets others' innovations, not developing new drugs themselves.
  • Juvenescence partners with them after Phase 2 trials for broader reach and funding.
ANECDOTE

Liver Regeneration

  • Liver regeneration is being tested by implanting healthy hepatocytes into lymph nodes.
  • This could revolutionize liver failure treatment, making transplants less necessary.
Get the Snipd Podcast app to discover more snips from this episode
Get the app